Exosomal CircGANAB promotes cancer progression and immunotherapy resistance by degrading interacting RNAs and limiting T cell infiltration in pancreatic ductal adenocarcinoma. - Wong CH; Peña-Paladines JJ; Luo Z; Ma CY; Lee YL; Lin ZX; Xian YF; Hollingsworth MA; To KF; Chen Y (Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2026)